Aspect Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.02K Hold
115
– – ﹤0.01% 396
2026
Q2
$4.91K Buy
115
+6
+6% +$326 ﹤0.01% 417
2026
Q1
$6.84K Buy
109
+2
+2% +$160 ﹤0.01% 314
2025
Q4
$10.2K Sell
107
-2
-2% -$196 ﹤0.01% 263
2025
Q3
$10.6K Sell
109
-13
-11% -$1.35K ﹤0.01% 296
2025
Q2
$13.1K Buy
122
+32
+36% +$3.24K 0.01% 255
2025
Q1
$9.08K Hold
90
– – 0.01% 273
2024
Q4
$8.04K Sell
90
-162
-64% -$14.3K ﹤0.01% 314
2024
Q3
$21.1K Buy
252
+20
+9% +$1.58K 0.01% 179
2024
Q2
$17.9K Buy
232
+54
+30% +$3.95K 0.01% 198
2024
Q1
$12.2K Hold
178
– – 0.01% 249
2023
Q4
$10.3K Buy
+178
New +$9.5K 0.01% 254

Other funds holding BSX

Aspect Partners's BSX Position: Q3 2026 in Review

Aspect Partners held its Boston Scientific (BSX) position steady in Q3 2026 at 115 shares worth $5.02K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Aspect Partners first reported a position in BSX in Q4 2023 and has held it in 12 quarters since. The position peaked at $21.1K in Q3 2024. 335 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Aspect Partners held 115 shares of Boston Scientific worth $5.02K as of Q3 2026.
  • Aspect Partners left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #396 holding.
  • Aspect Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Boston Scientific position peaked at $21.1K in Q3 2024.
  • 335 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.